Cardiff Oncology (CRDF) Stock Highlights

4.26 | -5.12%

2024-12-21 06:37:01

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Statistics

Range Today

4.2 4.67

Volume Today 2.1M

Range 1 Year

1.37 6.42

Volume 1 Year 298.05M

Range 3 Year

0.94 7.32

Volume 3 Year 584.73M

Range 10 Year

0.7 977.76

Volume 10 Year 1.38B

Highlights

Market Capitalization 143.37M (small)

Floating Shares 45.2K

Current Price 4.26

Price To Earnings -4.48

Price To Revenue -81.15

Price To Book 0

Earnings Per Share -0.92

Payout Ratio 0%

Performance

Latest -5.12%

1 Month +60.75%

3 Months +69.05%

6 Months +70.4%

1 Year +208.7%

3 Years -28.64%

5 Years +225.19%

10 Years -98.68%

Benchmarks

Market Capitalization

272 / 368

Gross Profits

177 / 278

Total Revenue

252 / 300

Total Rank

300 / 368

Free Cashflow

134 / 352

Performance 5 years

32 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.